Literature DB >> 2901126

Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.

L T Meltzer1, J N Wiley, A E Williams, T G Heffner.   

Abstract

The ability of B-HT 920, a selective dopamine (DA) D-2 agonist, to stimulate postsynaptic DA receptors in brain was evaluated by assessing its ability to induce stereotypy and to increase locomotor activity in rats. When administered alone, B-HT 920 (0.03-3.0 mg/kg) did not induce stereotypy and produced only inhibition of locomotor activity, suggesting a lack of postsynaptic DA agonist actions. However, a different pattern of effects emerged when B-HT 920 was administered in combination with the selective DA D-1 agonist SKF 38393 (10 mg/kg): stereotypies (sniffing, licking, and gnawing) were induced and there was an inverted U-shaped function for locomotor activity. These data are consistent with the hypothesis that B-HT 920 has postsynaptic DA D-2 receptor agonist effects in normal rats that are revealed when D-1 receptor stimulation is also increased.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901126     DOI: 10.1007/bf00181942

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.

Authors:  M Mashurano; J L Waddington
Journal:  Neuropharmacology       Date:  1986-08       Impact factor: 5.250

3.  Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.

Authors:  N E Andén; M Grabowska-Andén
Journal:  Acta Physiol Scand       Date:  1987-09

4.  Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393.

Authors:  S Hjorth; A Carlsson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study.

Authors:  J H Carlson; D A Bergstrom; J R Walters
Journal:  Brain Res       Date:  1987-01-06       Impact factor: 3.252

6.  Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.

Authors:  N E Andén; H Nilsson; E Ros; U Thornström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-01

7.  The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.

Authors:  D Hinzen; O Hornykiewicz; W Kobinger; L Pichler; C Pifl; G Schingnitz
Journal:  Eur J Pharmacol       Date:  1986-11-12       Impact factor: 4.432

8.  Behavioral correlations of dopamine receptor activation.

Authors:  O Gershanik; R E Heikkila; R C Duvoisin
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat.

Authors:  E Eriksson; K Svensson; D Clark
Journal:  Life Sci       Date:  1985-05-13       Impact factor: 5.037

10.  The central effects of a novel dopamine agonist.

Authors:  P E Setler; H M Sarau; C L Zirkle; H L Saunders
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

View more
  7 in total

1.  Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.

Authors:  S Matsumoto; K Yamada; M Nagashima; M Domae; K Shirakawa; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

2.  Involvement of central beta-adrenoceptors in the regulation of yawning responses.

Authors:  K Yamada; S Matsumoto; M Nagashima; M Kumagai; H Kimura; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

3.  Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.

Authors:  P B Clarke; K J Wyder; A Jakubovic; H C Fibiger
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

4.  Chronic imipramine "reverses" B-HT 920-induced hypomotility in rats.

Authors:  G Serra; M Collu; P S D'Aquila; G M De Montis; G L Gessa
Journal:  J Neural Transm Gen Sect       Date:  1991

5.  Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

6.  Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.

Authors:  K Yamada; M Nagashima; H Kimura; S Matsumoto; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.

Authors:  K Yamada; S Matsumoto; M Nagashima; K Shirakawa; T Furukawa
Journal:  J Neural Transm Gen Sect       Date:  1990
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.